Rhabdomyolysis after BNT162b2 mRNA Covid-19 vaccine in an adolescent male

Pfizer-BioNTech COVID-19 (BNT162b2) conferred a high level of protection against Covid-19 with a proven short-term safety profile. Although cases of vaccine-associated myopericarditis have been reported, the existence of rhabdomyolysis without myocarditis has not yet been published. A 16-year-old, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Sutcu, Murat, Gul, Doruk, Atik, Fatih, Kara, Manolya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Medical Association Of Malawi 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356520/
https://www.ncbi.nlm.nih.gov/pubmed/35991822
http://dx.doi.org/10.4314/mmj.v34i2.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356520/
https://www.ncbi.nlm.nih.gov/pubmed/35991822
http://dx.doi.org/10.4314/mmj.v34i2.13

Ejemplares similares